HUNAN WARRANT PHARMACEUTICAL CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.06 CNY | +0.99% |
|
+0.13% | -7.93% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 1.72B 238M | Sales 2025 * | 2B 276M | Capitalization | 4.23B 585M |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 2.46 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.12 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 1,162 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 31.63% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.99% | ||
| 1 week | +0.13% | ||
| Current month | +0.13% | ||
| 1 month | -12.99% | ||
| 3 months | +21.95% | ||
| 6 months | +0.96% | ||
| Current year | -7.93% |
1 week
44.22
45.98
1 month
42.6651.99
Current year
30.0252.97
1 year
30.0252.97
3 years
28.3169.98
5 years
28.3169.98
10 years
28.3169.98
| Managers | Title | Age | Since |
|---|---|---|---|
Ben Dong Huang
CEO | Chief Executive Officer | 60 | 11-02-28 |
Xiang Qi Cao
DFI | Director of Finance/CFO | 50 | 21-10-31 |
Xiang Gao
BRD | Director/Board Member | 53 | 02-09-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Fei Ma
BRD | Director/Board Member | 53 | 21-10-25 |
Peng Zhang
BRD | Director/Board Member | 48 | 22-04-17 |
Cai Lian Kang
BRD | Director/Board Member | 50 | 21-10-25 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-07 | 45.06 | +0.99% | 1,223,350 |
| 24-05-06 | 44.62 | -0.84% | 2,608,258 |
| 24-04-30 | 45 | -5.62% | 2,905,295 |
End-of-day quote Shanghai S.E., May 06, 2024
More quotes
Hunan Warrant Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of chemical raw materials, chemical pharmaceutical preparations and traditional Chinese medicine preparations. The Company's products include pharmaceutical preparations, raw materials and intermediates, plant extracts and food. Its products cover areas such as digestion, breathing, and anti-infection. The Company mainly conducts business within the domestic market.
Sector
Pharmaceuticals
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
45.06
CNY
Average target price
59
CNY
Spread / Average Target
+30.94%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.93% | 586M | |
| +33.43% | 700B | |
| +27.80% | 569B | |
| -5.12% | 358B | |
| +19.59% | 330B | |
| +4.89% | 287B | |
| +16.00% | 236B | |
| +6.73% | 202B | |
| -9.45% | 197B | |
| +4.26% | 161B |
- Stock Market
- Equities
- 688799 Stock